论文信息 - Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? - 字舞流文

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

A. Carraturo | L. Alibardi | M. Lichtner | S. Vita | C. Mastroianni | P. Dolce | C. Cosentino | C. Del Borgo | A. Mecozzi | D. Pacella | R. Marocco | V. Belvisi | A. Carraro | B. Kertusha | M. De Masi | M. Aiuti | A. De Meo | S. Parrocchia | P. Redaelli | C. L. L. M. A. S. A. A. Cosentino Alibardi De Marchis Aiuti Carraturo Parr | L. De Marchis

[1] A. Anselmo,et al. A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant Klebsiella pneumoniae Nosocomial Strains Isolated during an MDR Surveillance Program , 2020, Antibiotics.

[2] Cosimo Distante,et al. Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy , 2020, International journal of environmental research and public health.

[3] Y. Carmeli,et al. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control , 2017, Infection Control & Hospital Epidemiology.

[4] Kerri A. Thom,et al. Transfer of multidrug-resistant bacteria to healthcare workers’ gloves and gowns after patient contact increases with environmental contamination* , 2012, Critical care medicine.

[5] M. Synnestvedt,et al. Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae , 2009, Infection Control & Hospital Epidemiology.

[6] M. Jackson,et al. Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.